Skip to content

Research on Molecular Biomarkers Associated with Cardiorenal Risk in Patients with Hypertension and Metabolic Syndrome

Research on Molecular Biomarkers Associated with Cardiorenal Risk in Patients with Hypertension and Metabolic Syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106907
Enrollment
Unknown
Registered
2025-07-31
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension with metabolic syndrome

Interventions

Hypertension with metabolic syndrome group
Hypertension without metabolic syndrome group
:None

Sponsors

Beijing Friendship Hospital ,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years, without gender restriction; 2.Previously confirmed diagnosis of hypertension, with routine health examination records including complete blood count (CBC), urinalysis, and stool analysis; 3.Participants or legal guardians capable of understanding and willing to comply with study protocols, who voluntarily participate and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Patients with severe organ dysfunction or extreme debilitation; 3.Other conditions deemed ineligible by the investigator for this clinical trial.

Design outcomes

Primary

MeasureTime frame
Plasma concentrations of glycocalyx degradation markers;Fecalomics;Environmental pollutant levels;Cardiorenal composite endpoint;

Countries

China

Contacts

Public ContactRongchong Huang

Beijing Friendship Hospital ,Capital Medical University

rchuang@aliyun.com+86 10 63138217

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026